​PRESENTATIONS

​

Speaker/Moderator Bios are available here.

​

Day 1 - Wednesday, September 4, 2024

• Housekeeping and Rules of Engagement​

Mary Devlin Capizzi, IPAC-RS Secretariat

• Welcome, Workshop Objectives, & Introductions

Chris Vernall, Intertek, (Co-Chair)

• Classes of Inhaled and Nasal Biologics: Current Trends in the Industry

Tomaso Guidi, Chiesi Farmaceutici S.p.A.

• Overview of Regulatory Landscape

Ruth Cordoba-Rodriguez, AstraZeneca

• Testing Requirements for Protein Biologics Therapies

Wai Lam Ling, Catalent

• Preclinical Toxicology: Navigating the Respiratory Tract Barrier

Emily Resseguie, Labcorp Early Development Laboratories

• Testing for Inhaled and Nasal Oligonucleotide and mRNA Products

Ashleigh Wake, Intertek

• Relevance of Protein Aggregation in the Lung

Markus Fridén, AstraZeneca

• BREAKOUTS​

​

Day 2 - Thursday, September 5, 2024

• Welcome & Workshop Objective - Day 2

Alan Watts, Catalent (Co-Chair)

• Excipients for Respiratory Delivery of Large Molecules

Diana Fernandes, invoX

Michael Shultz/Kim Shepard, Lonza

• Spray Drying of Biologics

Sune Klint Andersen, Janssen

• A Platform Approach to Spray Dried, Thermostable, Mucosal Vaccines

Reinhard Vehring, Access to Advanced Health Institute

• Influence of Device on Aqueous Stability  [Presentation not yet available.  Contact speaker for information.]

Ronan MacLoughlin, Aerogen

• Particle Precision: The Importance of Sample Preparation in Insoluble Particle Analysis in Inhaled Biologic Powders

Scott Sides, AstraZeneca

• Collection and Detection Strategies for Inhaled Biologics

Philip Kuehl, Lovelace Biomedical
Chris Gruenloh, PPD, a part of Thermo Fisher Scientific